Estrogen Induces Insulin-Like Growth Factor-1 mRNA Expression in the Immortalized Hippocampal Cell: Determination by Quantitative Real-Time Polymerase Chain Reaction

Neurochemical Research

Volumn 28, Issue 9, 2003, Pages 1379-1383

  Shingo, Akiko S ^a   Kito, Shozo ^a  

^a HYOGO UNIVERSITY   (Japan)

Author keywords

Estrogen; H19 7; Hippocampus; IGF 1; PCR

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; MESSENGER RNA; SOMATOMEDIN C;

ACCURACY; ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; HIPPOCAMPUS; HORMONAL REGULATION; HORMONE INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REPRODUCIBILITY; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; POLYMERASE CHAIN REACTION;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

ANIMALS; CELL LINE; ESTRADIOL; HIPPOCAMPUS; INSULIN-LIKE GROWTH FACTOR I; POLYMERASE CHAIN REACTION; RATS; RNA, MESSENGER;

EID: 0042379962     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024900616704     Document Type: Article

References (20)

1. Shingo, A. S., Miyoshi, R., Kondo, K., and Kito, S. 1997. Estrogen as a repair system in brain by inducing IGF-1 mRNA. Soc. Neurosci. Abstr. 23:670.12.
2. Shingo, A. S., Miyoshi, R., and Kito, S. 1998. Mechanisms of estrogen action as a repair system in brain. Soc. Neurosci. Abstr. 24:511-516.
3. Eves, E. M., Boise, H. L., Thompson, C. B., Wagner, A. J., Hay, N., and Rosner, M. R. 1996. Apoptosis induced by differentiation or serum deprivation in an immortalized central nervous system neuronal cell line. J. Neurochem. 67:1908-1920.
4. Komourian, J. and Quik, M. 1996. Characterization of nicotinic receptors in immortalized hippocampal neurons. Brain Res. 718:37-45.
5. Morrione, A., Romano, G., Navarro, M., Reiss, K., Valentinis, B., Dews, M., Eves, E., Rosner, M. R., and Baserga, R. 2000. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells. Cancer Res. 60:2263-2272.
6. Ceil, F. S., Cohen, M. M., Antonarakis, S. E., Wertheimer, E., Roth, J., and Shuldiner, A. R. 1994. Determination of gene dosage by a quantitative adaptation of the polymerase chain reaction (gd-PCR): Rapid detection of deletions and duplications of gene sequences. Genomics 21:304-310.
7. Bieche, I., Olive, M., Champeme, M. H., Vidaud, D., Lidereau, R., and Vidaud, M. 1998. Novel approach to quantitative polymerase chain reaction using real-time detection: Application to the detection of gene amplification in breast cancer. Int. J. Cancer 78:661-666.
8. Leventhal, P. S., Russel, J. W., and Feldman, E. L. 1999. IGFs and the nervous system. Pages 425-455, in Rosenfeld, R. G. and Roberts, C. T. (eds.), The IGF system, New Jersey, Humana Press.
9. McDonnell, D. P., Clemm, D. L., Hermann, T., Goldman, M. E., and Pike, J. W. 1995. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9:659-669.
10. Pink, J. J. and Jordan, V. C. 1996. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res. 56:2321-2233.
11. Tremblay, A., Tremblay, G. B., Labrie, F., and Giguere, V. 1999. Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1. Mol. Cell. 3:513-519.
12. Webb, P., Nguyen, P., Shinsako, J., Anderson, C., Feng, W., Nguyen, M. P., Chen, D., Huang, S. M., Subramanian, S., McKinerney, E., Katzenellenbogen, B. S., Stallcup, M. R., and Kushner, P. J. 1998. Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol. Endocrinol. 12:1605-1618.
13. Webb, P., Nguyen, P., Valentine, C., Lopez, G. N., Kwok, G. R., McInerney, E., Katzenellenbogen, B. S., Enmark, E., Gustafsson, J. A., Nilsson, S., and Kushner, P. J. 1999. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol. Endocrinol. 13:1672-1685.
14. Lees, J. A., Fawell, S. E., and Parker, M. G. 1989. Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res. 684:5477-5488.
15. Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scherr, E., and Champbon, P. 1989. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59:477-487.
16. Aronica, S. M. and Katzenellenbogen, B. S. 1993. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1. Mol. Endocrinol. 7:743-752.
17. Morley, P., Whitfield, J. F., Vanderhyden, B. C., Tsang, B. K., and Schwartz, J. L. 1992. A new, nongenomic estrogen action: The rapid release of intracellular calcium. Endocrinology 131:1305-1312.
18. Shingo, A. S. and Kito, S. 2002. Estrogen induces elevation of cAMP-dependent protein kinase activity in immortalized hippocampal neurons: Imaging in living cells. J. Neural. Transm. 109:171-174.
19. Meyer, T. E. and Habener, J. F. 1993. Cyclic adenosine 3′,5-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocrinol. Rev. 14:269-290.
20. Zhou, Y., Watters, J. J., and Dorsa, D. M. 1996. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137:2163-2166.